In this Q&A, Daniel Buckley, Associate Director of CDO Downstream Development at Samsung Biologics, explains how developers can best evaluate a CDMO’s capabilities and how Samsung Biologics supports clients through innovative technologies and best-in-class solutions.
.svg)
